Abstract:
Vulvar cancer is a rare malignant tumor, accounting for 3–8% of the total incidence of malignant tumors of the female reproductive system. However, in the structure of mortality, this pathology ranks fourth after cancer of the cervix, uterine body and ovaries and amounts to 18.2%. Features of the anatomical structure of the external genital organs of a woman with a developed system of blood and lymphatic vessels cause an aggressive course, a tendency to metastasis and rapid growth of a tumor of this localization. Prospects for the timely diagnosis of vulvar cancer and vaginal tumors are directly related to an increase in literacy and oncological alertness of staff in general medical institutions, in the implementation of which not only the detection of the disease in the early stages, but also work with women from risk groups to refer them to further examination and, if necessary, for treatment in a specialized institution. High mortality from these diseases is associated with the appeal of women at the late stages of the development of the oncological process, as well as with the insufficient effectiveness of the therapy, which necessitates the development of research in this area.
